PL1620425T3 - Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu - Google Patents

Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu

Info

Publication number
PL1620425T3
PL1620425T3 PL04726965T PL04726965T PL1620425T3 PL 1620425 T3 PL1620425 T3 PL 1620425T3 PL 04726965 T PL04726965 T PL 04726965T PL 04726965 T PL04726965 T PL 04726965T PL 1620425 T3 PL1620425 T3 PL 1620425T3
Authority
PL
Poland
Prior art keywords
glucagon receptor
substituted
receptor antagonists
cyanothiophene
acetamides
Prior art date
Application number
PL04726965T
Other languages
English (en)
Inventor
Shawn David Erickson
Paul Gillespie
Kevin Richard Guertin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL1620425T3 publication Critical patent/PL1620425T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
PL04726965T 2003-04-16 2004-04-13 Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu PL1620425T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46320003P 2003-04-16 2003-04-16
PCT/EP2004/003884 WO2004092156A1 (en) 2003-04-16 2004-04-13 Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
EP04726965A EP1620425B1 (en) 2003-04-16 2004-04-13 Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists

Publications (1)

Publication Number Publication Date
PL1620425T3 true PL1620425T3 (pl) 2009-06-30

Family

ID=33300050

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04726965T PL1620425T3 (pl) 2003-04-16 2004-04-13 Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu

Country Status (15)

Country Link
US (1) US7138529B2 (pl)
EP (1) EP1620425B1 (pl)
JP (1) JP4599347B2 (pl)
KR (1) KR100779324B1 (pl)
CN (1) CN100398533C (pl)
AT (1) ATE418548T1 (pl)
AU (1) AU2004230220B2 (pl)
BR (1) BRPI0409454A (pl)
CA (1) CA2521732C (pl)
DE (1) DE602004018630D1 (pl)
ES (1) ES2316978T3 (pl)
MX (1) MXPA05010998A (pl)
PL (1) PL1620425T3 (pl)
RU (1) RU2336274C2 (pl)
WO (1) WO2004092156A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
WO2004024065A2 (en) * 2002-09-12 2004-03-25 Merck & Co., Inc. Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
RS50613B (sr) * 2004-05-28 2010-06-30 4Sc Ag Tetrahidropiridotiofeni
DE602005007220D1 (de) * 2004-06-04 2008-07-10 Nycomed Gmbh Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
JP2008501768A (ja) * 2004-06-11 2008-01-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の化合物及びテトラヒドロピリドチオフェンの使用
US20090209534A1 (en) * 2004-06-11 2009-08-20 Klaus Pekari Novel compounds and use of tetrahydropyridopyridothiophenes
DE102004051188A1 (de) * 2004-10-21 2006-04-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Cyanothiophene, deren Herstellung und deren Verwendung als Arzneimittel
JP2008529989A (ja) * 2005-02-09 2008-08-07 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 癌のような増殖性の疾病の治療用のテトラヒドロピリドチオフェン
US7741488B2 (en) * 2005-02-11 2010-06-22 4Sc Ag Tetrahydropyridothiophenes as antiproliferative agents for the treatment of cancer
US20090252706A1 (en) * 2005-02-11 2009-10-08 Klaus Pekari Tetrahydropyridothiophenes As Antripoliferative Agents For The Treatment Of Cancer
AU2006251167A1 (en) * 2005-05-25 2006-11-30 4Sc Ag Tetrahydropyridothiophenes for use in the treatment of cancer
CA2609004A1 (en) * 2005-05-25 2006-11-30 Nycomed Gmbh Tetrahydropyridothiophenes for use in the treatment of cancer
KR20190126460A (ko) * 2007-02-09 2019-11-11 메타베이시스 테라퓨틱스, 인크. 글루카곤 수용체의 길항제
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
ES2714207T3 (es) 2008-08-13 2019-05-27 Metabasis Therapeutics Inc Antagonistas de glucagón
WO2012085745A1 (en) 2010-12-23 2012-06-28 Pfizer Inc. Glucagon receptor modulators
EA023517B1 (ru) 2011-02-08 2016-06-30 Пфайзер Инк. Модуляторы глюкагонового рецептора
CN103732578B (zh) 2011-07-22 2015-08-12 辉瑞大药厂 喹啉基胰高血糖素受体调节剂
JP2017519000A (ja) 2014-06-12 2017-07-13 リガンド・ファーマシューティカルズ・インコーポレイテッド グルカゴンアンタゴニスト
WO2015197861A1 (en) 2014-06-27 2015-12-30 Nogra Pharma Limited Aryl receptor modulators and methods of making and using the same
SG11202012625PA (en) * 2018-06-19 2021-01-28 Novartis Ag N-substituted tetrahydrothienopyridine derivatives and uses thereof
CN114957278B (zh) * 2021-02-20 2023-08-11 兰州大学 胰高血糖素受体拮抗剂及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206375A (en) * 1985-03-02 1993-04-27 Basf Aktiengesellschaft Thiophene derivatives
DE4236400A1 (de) * 1992-10-28 1994-05-05 Bayer Ag N-Phenylacetaminonitrile
ATE208779T1 (de) * 1993-07-02 2001-11-15 Bayer Ag Substituierte spiroheterocyclische 1h-3-aryl- pyrrolidin-2,4-dion-derivate, verfahren zu deren herstellung und deren verwendung als schädlingsbekämpfungsmittel
WO1998040385A1 (en) 1997-03-07 1998-09-17 Novo Nordisk A/S 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
WO1999046267A1 (en) 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
AU5154699A (en) 1998-09-02 2000-03-27 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-c)pyridine derivatives
US20020045613A1 (en) * 2000-04-27 2002-04-18 Heinz Pauls 1-aroyl-piperidinyl benzamidines
GB0114185D0 (en) * 2001-06-12 2001-08-01 Protherics Molecular Design Lt Compounds
EP1384715A4 (en) * 2001-04-11 2005-06-01 Senju Pharma Co NOVEL IMIDAZOLIDINEDIONE DERIVATIVES AND THEIR USE AS A MEDICINAL PRODUCT
EP1383771A1 (en) * 2001-04-20 2004-01-28 Vertex Pharmaceuticals Incorporated 9-deazaguanine derivatives as inhibitors of gsk-3
WO2004024066A2 (en) 2002-09-12 2004-03-25 Merck & Co., Inc. Method of treating diabetes and related conditions
WO2004024065A2 (en) 2002-09-12 2004-03-25 Merck & Co., Inc. Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use
US7196106B2 (en) 2002-11-05 2007-03-27 Merck & Co., Inc Cyanothiophene derivatives, compositions containing such compounds and methods of use

Also Published As

Publication number Publication date
WO2004092156A1 (en) 2004-10-28
CA2521732A1 (en) 2004-10-28
JP4599347B2 (ja) 2010-12-15
CN1774433A (zh) 2006-05-17
MXPA05010998A (es) 2005-12-12
BRPI0409454A (pt) 2006-05-02
EP1620425B1 (en) 2008-12-24
JP2006523641A (ja) 2006-10-19
ATE418548T1 (de) 2009-01-15
RU2005135338A (ru) 2007-05-27
KR100779324B1 (ko) 2007-11-28
KR20060011959A (ko) 2006-02-06
CA2521732C (en) 2011-06-07
AU2004230220A1 (en) 2004-10-28
AU2004230220B2 (en) 2009-09-17
US20040209943A1 (en) 2004-10-21
DE602004018630D1 (en) 2009-02-05
RU2336274C2 (ru) 2008-10-20
EP1620425A1 (en) 2006-02-01
US7138529B2 (en) 2006-11-21
ES2316978T3 (es) 2009-04-16
CN100398533C (zh) 2008-07-02

Similar Documents

Publication Publication Date Title
PL1620425T3 (pl) Podstawione 3-cyjanotiofenoacetamidy jako antagoniści receptora glukagonu
WO2005075450A3 (en) Spiro-benzodioxoles and their use as cb1 antagonists
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
TW200606151A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
ATE384050T1 (de) Benzazepinderivate als histamin-h3-antagonisten
GB0625648D0 (en) Compounds
TW200505919A (en) DPP-IV inhibitors
TW200630374A (en) Thiazolyldihydroindazoles
WO2004013120A8 (en) Novel benzodioxoles
PL2029529T3 (pl) PODSTAWIONE PIROLIDYNONY JAKO INHIBITORY DEHYDROGENAZY 11-ß-HYDROKSYSTEROIDOWEJ TYPU 1
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
MX2009005358A (es) Derivados de 5-sulfanilmetil-pirazolo[1,5-a]pirimidin-7-ol como antagonistas de cxcr2.
WO2006100081A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
SI1828177T1 (sl) Novi antagonisti mch receptorja
NO20070089L (no) DPP-IV inhibitorer
DE602004011394D1 (en) Thiazolderivate
MX2009003125A (es) Tiazol pirazolopirimidinas como antagonistas de receptor de crf1.
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
IS8377A (is) Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
MX2009005174A (es) Derivados de 5-sulfanilmetil-[1,2,4]triazol[1,5-a]pirimidin-7-ol como antagonistas de cxcr2.
IL201317A0 (en) Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
ATE467636T1 (de) Pyrazoloä3 , 4-düazepinderivate als histamin-h3- antagonisten
TW200634013A (en) Quinoline derivative, its use, production and pharmaceutical agents containing the derivative
TW200628153A (en) Novel compounds